- Home
- / Jubilant Pharmova
Jubilant Pharmova
Stock Price
₹1.1 K
2024-10-29
Market Capitalization
₹169.2 B
2024-10-29
Revenue
₹71.9 B
FY, 2025
Jubilant Pharmova Summary
Company Summary
- Overview
- Jubilant Pharmova is a manufacturer of radiopharmaceuticals. It offers contract research and development, proprietary novel drugs, solid dosage formulations, and other services for the healthcare sector.
- Type
- Public
- Status
- Active
- Founded
- 1978
- HQ
- Noida, IN | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
22 locations detected
Noida, UP HQ
India
1A, Sector 16A
Bedminster, NJ
United States
1430 US Highway 206, Suite 110
Salisbury, MD
United States
207 Kiley Dr
Spokane, WA
United States
3525 N Regal St
Yardley, PA
United States
790 Township Line Road, Suite 325
Southbank, VIC
Australia
Level 13, Freshwater Place, 2 Southbank Boulevard
Jubilant Pharmova Financials
Summary Financials
- Revenue (Q3, 2026)
- ₹21.2B
- Gross profit (Q3, 2026)
- ₹14.3B
- Net income (Q3, 2026)
- ₹558.0M
- Cash (Q2, 2026)
- ₹6.2B
- EBIT (Q3, 2026)
- ₹1.5B
- Enterprise value
- $191.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026